Risk factors for neutropenic fever in lymphoma patients receiving chemotherapy

被引：0
|
作者：
Teegala, S. R. [1 ]
Zhou, X. [1 ]
Huen, A. [1 ]
Ji, Y. [1 ]
Fayad, L. E. [1 ]
Romaguera, J. E. [1 ]
Vadhan-Raj, S. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19616
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neutropenic Fever Following Chemotherapy in a Patient With Lymphoma
    Book, Lisa
    ONCOLOGY NURSING FORUM, 2008, 35 (06) : 885 - 887
  • [2] Incidence and risk factors for severe thrombocytopenia in lymphoma patients receiving chemotherapy.
    Zhou, Xiao
    Teegala, Shyam
    Ji, Yuan
    Fayad, Luis
    Romaguera, Jorge Enrique
    Hagemeister, F. B.
    Vadhan-Raj, Saroj
    BLOOD, 2006, 108 (11) : 76B - 76B
  • [3] Predicting Individual Risk of Neutropenic Complications in Patients Receiving Cancer Chemotherapy
    Lyman, Gary H.
    Kuderer, Nicole M.
    Crawford, Jeffrey
    Wolff, Debra A.
    Culakova, Eva
    Poniewierski, Marek S.
    Dale, David C.
    CANCER, 2011, 117 (09) : 1917 - 1927
  • [4] RISK FACTORS FOR FEVER AND INFECTIONS IN NEUTROPENIC PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
    Sotiropoulos, D.
    Syrigou, A.
    Neokleous, N.
    Karpouza, A.
    Bitzioni, A.
    Tsorlini, E.
    Anagnostopoulos, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 477 - 477
  • [5] Final Risk Prediction Model for Neutropenic Complications in Patients Receiving Cancer Chemotherapy
    Lyman, Gary H.
    Crawford, Jeffrey
    Kuderer, Nicole M.
    Wolff, Debra
    Culakova, Eva
    Poniewierski, Marek S.
    Dale, David C.
    BLOOD, 2008, 112 (11) : 474 - 475
  • [6] Risk of neutropenic complications in patients receiving systemic chemotherapy: Prospective risk model development.
    Crawford, J
    Dale, DC
    Wolff, D
    Agboola, O
    Culakova, E
    Lyman, GH
    BLOOD, 2003, 102 (11) : 168B - 169B
  • [7] High incidence of venous thromboembolism in patients with lymphoma receiving chemotherapy: Assessment of risk factors.
    Teegala, Shyam
    Zhou, Xiao
    Huen, Auris
    Fayad, Luis
    Romaguera, Jorge Enrique
    Hagemeister, F. B.
    Vadhan-Raj, Saroj
    BLOOD, 2006, 108 (11) : 105B - 106B
  • [8] Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer
    Sharma, Sameer
    Rezai, Katayoun
    Driscoll, Deborah
    Odunsi, Kunle
    Lele, Shashikant
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 181 - 185
  • [9] RISK FACTORS FOR BACTEREMIA IN PEDIATRIC PATIENTS WITH CANCER AND NON-NEUTROPENIC FEVER
    Beauchemin, Melissa M.
    Fernbach, Alison E.
    Lopez, Ibis
    Kelly, Kara M.
    Sulis, Maria Luisa
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1113 - 1113
  • [10] Neutropenic events in patients receiving CHOP chemotherapy for large cell non-Hodgkin's lymphoma: Predicting who is at risk.
    Tompkins, KA
    Imrie, KR
    BLOOD, 2001, 98 (11) : 337A - 338A
12345